ABCL, TGNA and BOXL are showing great entries for long term investments that may provide more than 300% return. Interest rate cuts may accelerate the process.
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera's full-stack, Artificial Intelligence-powered drug discovery platform integrates modern technologies from engineering, microfluidics, single-cell analysis, high-throughput...
